Trimurthi Drugs & Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on April 11, 2015, to consider the redesignation of the Arun kumar Bhangadia as Executive Chairman (Director) of the Company and consider remuneration payable, terms and Conditions of appointment based on recommendations by the Remuneration Committee.
The above information is a part of company’s filings submitted to BSE.